BIODRONE Trademark

Trademark Overview


On Wednesday, August 9, 2017, a trademark application was filed for BIODRONE with the United States Patent and Trademark Office. The USPTO has given the BIODRONE trademark a serial number of 79218221. The federal status of this trademark filing is REGISTERED as of Tuesday, August 28, 2018. This trademark is owned by MDimune Inc.. The BIODRONE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for treating ulcers; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for use in urology; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic preparations for medical or veterinary purposes; diagnostic reagents and contrast media for medical purposes; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for medical diagnosis; anti-cancer preparations; tumor suppressing agents
biodrone

General Information


Serial Number79218221
Word MarkBIODRONE
Filing DateWednesday, August 9, 2017
Status700 - REGISTERED
Status DateTuesday, August 28, 2018
Registration Number5547866
Registration DateTuesday, August 28, 2018
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 12, 2018

Trademark Statements


Description of MarkThe mark consists of the wording "BIODRONE" in stylized form.
Goods and ServicesPharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for treating ulcers; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for use in urology; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic preparations for medical or veterinary purposes; diagnostic reagents and contrast media for medical purposes; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for medical diagnosis; anti-cancer preparations; tumor suppressing agents
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 17, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMDimune Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameMDimune Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameMDimune Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, August 28, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 3, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 28, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 10, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, December 10, 2018FINAL DISPOSITION PROCESSED
Wednesday, November 28, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 28, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, June 12, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2018PUBLISHED FOR OPPOSITION
Friday, June 8, 2018NOTIFICATION PROCESSED BY IB
Wednesday, May 23, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 23, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 23, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, May 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 17, 2017REFUSAL PROCESSED BY IB
Wednesday, November 29, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 29, 2017REFUSAL PROCESSED BY MPU
Thursday, November 16, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 15, 2017NON-FINAL ACTION WRITTEN
Thursday, November 9, 2017ASSIGNED TO EXAMINER
Saturday, October 21, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, October 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 12, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB